论文部分内容阅读
乙酰螺旋霉素(Acetyl spiramy-cin)是大环内脂类抗菌素螺旋霉素乙酰化后的衍生物,对革蓝氏阳性球菌有较好的抗菌作用,口服吸收良好,迅速分布于体内,有较高的组织浓度,与其他抗菌素无交叉耐药性,国外已用于临床。我们于今年6月至8月应用中国医科院抗菌素研究所和无锡第二制药厂协作试制成功的乙酰螺旋霉素对40例急性细菌感染性疾病进行治疗和临床观察,现小结如下: 病例选择 任意选择住院和门诊的急性细菌感染患者40例作为治疗对象。计男性17例,女性23例。年龄11月一64岁。其中呼吸道感
Acetyl spiramy-cin is macrolide antibiotic spiramycin acetylated derivatives, has a good antibacterial activity against gram-positive cocci, oral absorption is good, quickly distributed in the body, there Higher tissue concentrations, no cross-resistance with other antibiotics, foreign countries have been used in clinical. We apply this year, June to August, the Chinese Academy of Medical Sciences Institute of antibiotics and Wuxi Second Pharmaceutical Co., Ltd. trial success of acetylspiramycin in 40 cases of acute bacterial infectious disease treatment and clinical observation, are summarized as follows: Case any Forty patients with acute bacterial inpatients and outpatients were selected as treatment subjects. 17 males and 23 females. Age of a 64-year-old. Which sense of the airways